Please wait ...

Details for messenger / hormone: EETs

EndoNet ID: ENH00961

To link to the content of EndoNet use the EndoNet ID that is given on the detail pages in the format ENX0000, where X is a place holder for the type of the component (e. g. R for receptor or C for anatomical structure).
As URL for the linking append this ID to the detail page for this type of component.
For an hormone that would be:

It is also possible to use the search of EndoNet to link to the right detail page. The URL should look like
If the search pattern is unambigious the user is directed to the corresponding detail page.


  • EETs
  • EDHFs
  • endothelium-derived hyperpolarizing factors
  • epoxyeicosatrienoic acids

General information

  • There are 3 principal mechanisms linked to the EDHF phenomenon: (1) an increase in endothelial [Ca2+] following cell stimulation triggers the synthesis of a CYP metabolite, which is essential for the subsequent EDHF-mediated responses; (2) K+, released from endothelial cells via Ca2+-dependent K+-channels, induces smooth muscle hyperpolarization by activating inwardly rectifying K+ channels and/or the Na+/K+-ATPase on vascular smooth muscle cells; and (3) endothelial cell hyperpolarization is transmitted to the vascular smooth muscle via gap junctions. [1]
  • EETs are arachidonic acid epoxides, and in mammals the epoxidation of polyunsaturated fatty acids to cis-epoxides is unique to the CYP enzyme system. [1]
  • EETs and their metabolites are potent vasodilators and are able to hyperpolarize both endothelial and vascular smooth muscle cells by activating Ca2+-dependent K+ channels. [1]
  • EETs are degraded by the soluble epoxide hydrolase as well as by ╬▓-oxidation, the exception being 5,6-EET, which is more rapidly metabolized by COX. [1]
  • Both 11,12- and 14,15-EET activate one or more metalloproteases and enhance endothelial cell migration as well as the release of HB-EGF from the cell surface. [1]
  • EETs released from astrocytes increase thymidine incorporation into endothelial cells and elicite the formation of capillary like structures. [1]
  • The CYP 2C8 and 2C9 promoters contain a glucocorticoid-responsive element that is recognized and transactivated by glucocorticoid receptor. Identification of this functional element provides a rational mechanistic basis for the induction of CYP 2C protein and an increase in EDHF-mediated responses in porcine coronary arteries by cortisol. [1]
  • EETs are also able to transactivate the EGF receptor in endothelial cells, and the activation of this particular signaling pathway has been linked to cell proliferation and angiogenesis. [1]
  • Multiple CYP enzymes are capable of generating EETs including members of the CYP 1A, CYP 2B, CYP 2C, CYP 2D, CYP 2J, and CYP 4A subfamilies. [1]
  • Mediate the NO- and prostacyclin (PGI2)-independent vasodilator responses in different arteries. [1]


Hormone function

  • homeostasis
    • cardiovascular control
      • ion flow control

      Chemical classification

      • hormone
        • not genome-encoded
          • eicosanoids/fatty acid derivatives


      Links to other resources

      • Anatomical structure: continuous_vascular_endothelial_cell_of_blood_vessels_and_lymphatics


      No records found.